Opko Health OPK
NASDAQ OPK
$1.72 +0.02 (+1.48%)
As of: Sep 22, 2026 · 10:52 AM EDT

Opko Health (OPK) Amortization of Deferred Charges (2013 - 2026)

Opko Health's (OPK) quarterly Amortization of Deferred Charges came in at $138000.0 in Q2 2026, down 96.95% on a YoY basis from $4.5 million in Q2 2025, and up 0.73% quarter-over-quarter from $137000.0 in Q1 2026.

Analysis

Opko Health (OPK) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends

Opko Health (OPK) has reported Amortization of Deferred Charges for 14 consecutive years, with $138000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortization of Deferred Charges fell 96.95% year-over-year to $138000.0; the trailing twelve-month figure through Jun 2026 stood at $550000.0 (down 92.4% YoY), and the FY2025 full-year result was $5.2 million, up 165.15% from the prior year.
  • Amortization of Deferred Charges advanced to $138000.0 in Q2 2026 per OPK's latest filing, from $137000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $4.5 million in Q2 2025 and bottomed at $137000.0 in Q4 2025.
  • Historically, Amortization of Deferred Charges has averaged $628529.4 across 5 years, with a median of $298000.0 in 2022.
  • The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges soared 378.75% in 2025, then slumped 96.95% in 2026.
  • Over 5 years, Amortization of Deferred Charges stood at $298000.0 in 2022, then rose by 5.37% to $314000.0 in 2023, then soared by 322.93% to $1.3 million in 2024, then slumped by 89.68% to $137000.0 in 2025, then gained by 0.73% to $138000.0 in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $138000.0, $137000.0, and $137000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138,000.00
Mar 31, 2026 137,000.00
Dec 31, 2025 137,000.00
Sep 30, 2025 138,000.00
Jun 30, 2025 4.53 Mn
Mar 31, 2025 430,000.00
Sep 30, 2024 1.33 Mn
Jun 30, 2024 946,000.00
Mar 31, 2024 519,000.00
Dec 31, 2023 314,000.00
Sep 30, 2023 310,000.00
Jun 30, 2023 302,000.00
Mar 31, 2023 296,000.00
Dec 31, 2022 298,000.00
Sep 30, 2022 294,000.00
Jun 30, 2022 288,000.00
Mar 31, 2022 281,000.00
Dec 31, 2021 182,000.00
Sep 30, 2021 179,000.00
Jun 30, 2021 202,000.00
API Access

Opko Health Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=OPK&period=max&api_key=YOUR_API_KEY